Iqvia Holdings (IQV) Gains from Investment Securities (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Gains from Investment Securities came in at -$18.0 million in Q1 2026, down 1700.0% year-on-year from $1.1 million in Q1 2025, and down 194.74% quarter-over-quarter from $19.0 million in Q4 2025.
Iqvia Holdings (IQV) Gains from Investment Securities (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Gains from Investment Securities across 15 years of filings, most recently posting -$18.0 million for Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at -$18.0 million, down 1700.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 million (up 225.0% YoY), and the FY2025 annual result was $22.0 million, up 1200.0% from the prior year.
- Gains from Investment Securities came in at -$18.0 million for Q1 2026 at Iqvia Holdings, down from $19.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $32.0 million in Q4 2023 to a low of -$31.0 million in Q4 2024.
- The 5-year median for Gains from Investment Securities is -$1.0 million (2024), against an average of $764705.9.
- Across the five-year window, Gains from Investment Securities jumped 300.0% in 2023 and plunged 1700.0% in 2026, its largest moves.
- Iqvia Holdings' Gains from Investment Securities stood at $8.0 million in 2022, then surged by 300.0% to $32.0 million in 2023, then slumped by 196.88% to -$31.0 million in 2024, then surged by 161.29% to $19.0 million in 2025, then plunged by 194.74% to -$18.0 million in 2026.
- The last three Gains from Investment Securities figures came in at -$18.0 million (Q1 2026), $19.0 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Quest Diagnostics | 22.46 Bn | 22.36 Bn | 942.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.00 Mn |
| Mar 31, 2026 | -18.00 Mn |
| Dec 31, 2025 | 19.00 Mn |
| Dec 31, 2025 | 19.00 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | -1.00 Mn |
| Jun 30, 2025 | -1.00 Mn |
| Mar 31, 2025 | -1.00 Mn |
| Mar 31, 2025 | -1.00 Mn |
| Dec 31, 2024 | -31.00 Mn |
| Dec 31, 2024 | -31.00 Mn |
| Sep 30, 2024 | 29.00 Mn |
| Sep 30, 2024 | 29.00 Mn |
| Jun 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | -1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 32.00 Mn |
| Dec 31, 2023 | 32.00 Mn |